The researchers built a combination nucleic acid-antibody test for the disease using an approach they said could be generally useful for rapid test development.
Rheonix has won an administrative supplement to an existing SBIR grant to develop the Zika test using its CARD cartridge and Encompass Optimum platform.
The firm's dual assay for host antigen to HIV as well as viral RNA was described in a proof-of-principle study earlier this year.
The Ithaca, New York-based firm will use the financing to ramp up commercialization of its molecular diagnostic testing platforms.
The firm is aiming at in vitro diagnostics, applied markets, and next-generation sequencing sample preparation.
The Phase II grant will provide the company with funding to develop a commercial-ready version of the test.
The fully automated self-confirming assay will simultaneously detect HIV/AIDS antibodies and viral RNA in a single specimen.
HandyLab has been awarded
NEW YORK (GenomeWeb) – Rheonix will soon begin a clinical trial for a microarray-based test for sexually transmitted infections with the aim of submitting the assay to the US Food and Drug Administration for clearance next year.
Lawrence Livermore National Security has been awarded
Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.
The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.
Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.
In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.